Lotte Biologics

Lotte Biologics to Construct 3 New Plants by 2030 After Land Purchase, Boosting Korean CDMO Capacity

Lotte Biologics to Construct 3 New Plants by 2030 After Land Purchase, Boosting Korean CDMO Capacity

Anika Sharma

Korean Contract Development and Manufacturing Organization (CDMO), Lotte Biologics, is embarking on an ambitious growth trajectory, aiming to achieve a ...